Xiamen Amoytop Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	3,696	2,809	2,093	1,517	1,123
Other Revenue	-	7.75	7.74	10	9.51
Revenue	3,696	2,817	2,100	1,527	1,132
Revenue Growth (YoY)	31.18%	34.13%	37.55%	34.86%	42.61%
Cost of Revenue	-	184.47	140.2	171.01	126.99
Gross Profit	3,696	2,633	1,960	1,356	1,005
Selling, General & Admin	-	1,393	1,060	841.02	700.65
Research & Development	-	292.02	228.52	148.58	79.74
Other Operating Expenses	2,442	13.3	10.95	7.64	5.55
Operating Expenses	2,442	1,702	1,300	995.83	783.6
Operating Income	1,254	930.33	659.88	360.06	221.64
Interest Expense	-	-0.45	-0.51	-0.62	-1.07
Interest & Investment Income	-	6.99	10.17	8.09	7.84
Currency Exchange Gain (Loss)	-	-0.12	-1.03	0.48	-0.47
Other Non Operating Income (Expenses)	-75.27	-0.09	-0.39	-0.25	-0.24
EBT Excluding Unusual Items	1,178	936.67	668.13	367.77	227.69
Gain (Loss) on Sale of Investments	-	0.88	2.65	0.4	1.8
Gain (Loss) on Sale of Assets	-	-0.03	-0.87	0.03	-1.8
Asset Writedown	-	-	-12.76	-	-
Other Unusual Items	-	-6.5	-16.49	-12.27	-12.4
Pretax Income	1,178	931.03	640.65	355.93	215.29
Income Tax Expense	140.59	103.42	85.21	68.91	34.09
Net Income	1,038	827.6	555.45	287.02	181.2
Net Income to Common	1,038	827.6	555.45	287.02	181.2
Net Income Growth	25.39%	49.00%	93.52%	58.40%	55.44%
Shares Outstanding (Basic)	407	408	405	404	403
Shares Outstanding (Diluted)	407	408	405	404	403
Shares Change (YoY)	-0.18%	0.56%	0.29%	0.39%	0.18%
EPS (Basic)	2.55	2.03	1.37	0.71	0.45
EPS (Diluted)	2.55	2.03	1.37	0.71	0.45
EPS Growth	25.62%	48.18%	92.96%	57.78%	55.17%
Free Cash Flow	-	179.28	223.64	143.99	43.85
Free Cash Flow Per Share	-	0.44	0.55	0.36	0.11
Dividend Per Share	-	0.620	0.410	0.213	0.100
Dividend Growth	-	51.22%	92.49%	113.00%	100.00%
Gross Margin	100.00%	93.45%	93.33%	88.80%	88.78%
Operating Margin	33.92%	33.02%	31.42%	23.58%	19.57%
Profit Margin	28.08%	29.38%	26.45%	18.80%	16.00%
Free Cash Flow Margin	-	6.36%	10.65%	9.43%	3.87%
EBITDA	1,313	989.71	713.25	403.23	260.33
EBITDA Margin	35.53%	35.13%	33.96%	26.41%	22.99%
D&A For EBITDA	59.38	59.38	53.37	43.17	38.69
EBIT	1,254	930.33	659.88	360.06	221.64
EBIT Margin	33.92%	33.02%	31.42%	23.58%	19.57%
Effective Tax Rate	11.93%	11.11%	13.30%	19.36%	15.83%
Revenue as Reported	-	2,817	2,100	1,527	1,132
Advertising Expenses	-	-	-	2.94	5.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.